Collins, Katharine A.
Brod, Florian
Snaith, Rebecca
Ulaszewska, Marta
Longley, Rhea J.
Salman, Ahmed M.
Gilbert, Sarah C.
Spencer, Alexandra J.
Franco, David
Ballou, W. Ripley
Hill, Adrian V. S.
Funding for this research was provided by:
Wellcome Trust (102051/Z/13/Z, 095540/Z/11/Z)
Article History
Received: 29 January 2020
Accepted: 10 May 2021
First Online: 24 May 2021
Competing interests
: KA Collins, SC Gilbert, AVS Hill are named as co-inventors on a patent filing related to the R21 immunogen; SC Gilbert and AVS Hill are co-inventors on patents relating the ME.TRAP vectored vaccines; D Franco and WR Ballou are employees of the GSK group of companies and WR Ballou reports owning shares and/or restricted shares in GSK. All other authors declare no competing financial interests.